Telehealth to Address Vaccine Hesitancy

This study is a 24-30 month behavioral intervention study to assess the impact of enrolling individuals a clinical pharmacist run telehealth education focused on wellness and vaccination. Individuals will be randomized to either a wellness only model focusing on nutrition, diabetes and hypertension or a wellness model with a vaccination education component. All participants will complete individual and group based interventions. Individuals will be recruited from industries with high risk for COVID-19 and other respiratory illness infection, such as health workers, teachers aides and the food industry. We are recruiting individuals who identify as African-American, Hispanic, come from a semi-rural/rural community or have additional social determinants of health that indicate social vulnerability. The primary outcome is COVID-19 vaccine completion. The secondary outcome is influenza vaccine completion.

Inclusion Criteria:Incomplete vaccination defined as 1a. Incomplete COVID-19 vaccine series 1b. Incomplete COVID-19 booster 1c. Incomplete annual influenzaAdults aged 18 years to 55 years of ageAble to speak EnglishCurrently employed or seeking training in target industries such as: healthcare, education, beauty, hospitality, food (culinary) and industrial plant workers.Able to use Telehealth technology via tablet, cell phone, or computerExclusion Criteria:Individuals who have completed the COVID-19 vaccine series and boosters.Individuals with documented allergy or reaction to COVID-19 or influenza vaccineIndividuals who are unable to give informed consent.Individuals with diagnosis of immunosuppressive conditions such as cancer, lupus, rheumatoid arthritis, Crohn's disease, Ulcerative Colitis, primary immunodeficiency, or organ transplant recipientsIndividuals diagnoses with congestive heart failureIndividuals diagnosed with any cardiac arrhythmia